Ingvild Haaland

Seniorrådgiver

Reg komité for forskningsetikk, Vest

Vitenskapelig artikkel

Vis forfatter(e) (2022). The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease . PLOS ONE.

Vis forfatter(e) (2021). p53 Protein Isoform Profiles in AML: Correlation with Distinct Differentiation Stages and Response to Epigenetic Differentiation Therapy. Cells. 14 sider.
Vis forfatter(e) (2021). The pulmonary mycobiome—A study of subjects with and without chronic obstructive pulmonary disease. PLOS ONE. 16 sider.
Vis forfatter(e) (2021). Repeated bronchoscopy in health and obstructive lung disease: is the airway microbiome stable? BMC Pulmonary Medicine. 1-12.
Vis forfatter(e) (2021). Exploring protocol bias in airway microbiome studies: one versus two PCR steps and 16S rRNA gene region V3 V4 versus V4. BMC Genomics. 15 sider.

Vis forfatter(e) (2020). A comparison of p53 isoform profiles and apoptosis induced by camptothecin or a herbal khat extract (Catha edulis (vahl) forssk. ex endl.) in leukemic cell lines: Exploring cellular responses in therapy development. Cancers. 1-14.

Vis forfatter(e) (2017). Protected sampling is preferable in bronchoscopic studies of the airway microbiome. European Respiratory Journal Open Research (ERJ Open Research).
Vis forfatter(e) (2017). A pilot study of hot-wire, ultrasonic and wedge-bellows spirometer inter- and intra-variability. BMC Research Notes.

Vis forfatter(e) (2014). The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences. European Clinical Respiratory Journal.
Vis forfatter(e) (2014). Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia. Molecular Cancer.

Vis forfatter(e) (2013). cAMP signalling inhibits p53 acetylation and apoptosis via HDAC and SIRT deacetylases. International Journal of Oncology. 1815-1821.

Vis forfatter(e) (2012). Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia. Leukemia. 910-917.
Vis forfatter(e) (2012). Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia. Oncogene. 1533-1545.

Vis forfatter(e) (2007). Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells. Molecular Cancer.

Vis forfatter(e) (2006). Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables. BMC Bioinformatics. 198.

Doktorgradsavhandling

Sammendrag/abstract

Vis forfatter(e) (2020). Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD. European Respiratory Journal.
Vis forfatter(e) (2020). Changes in the induced sputum proteome during COPD exacerbations. European Respiratory Journal.

Vis forfatter(e) (2019). Repeated bronchoscopy examination of the airway microbiome. European Respiratory Journal.
Vis forfatter(e) (2019). Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels. European Respiratory Journal.

Vis forfatter(e) (2014). Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients. European Respiratory Journal.

Vis forfatter(e) (2008). Evaluation of combinational therapy of MDM2-antagonist nutlin-3 and HDAC-inhibitor valproic acid in acute myeloid leukemia in vitro and in vivo. Blood. 1024-1024.

Poster

Vis forfatter(e) (2007). In vivo optical imaging of p53 specific targeted therapy in Acute Myeloid Leukaemia.

Vitenskapelig oversiktsartikkel/review

Vis forfatter(e) (2010). Clinical proteomics of myeloid leukemia. Genome Medicine.

Vis forfatter(e) (2006). Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia. Current Pharmaceutical Biotechnology. 199-207.